FIELD: pharmaceuticals.
SUBSTANCE: invention relates to 3-(2-oxo-4-phenylpyrrolidin-1-yl)propane-1-sulphonate, possessing anti-ischemic, antianginal, cytoprotective properties, nootropic activity and inhibiting development of neurodegenerative disease. Invention also relates to a method of producing 3-(2-oxo-4-phenylpyrrolidin-1-yl)propane-1-sulphonate calcium, use thereof and a method of treating said diseases based on use thereof.
EFFECT: obtaining a salt of a novel heterocyclic compound having useful biological properties.
6 cl, 15 tbl, 3 ex, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| 4-PHENYL PYRROLIDINONE-2 DERIVATIVE, NOOTROPIC COMPOSITION THEREOF, METHOD FOR PRODUCING THEREOF AND METHOD PREVENTIVE TREATMENT OF NERVOUS SYSTEM DISORDERS | 2015 |
|
RU2611623C2 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| MEDICATION POSSESSING ANTIDEPRESSIVE, ANXIOLYTIC AND NOOTROPIC ACTION | 2010 |
|
RU2437659C1 |
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| DERIVATIVE OF 3-HYDROXYPYRIDINE WITH ANXIOLYTIC AND NOOTROPIC EFFECT | 2017 |
|
RU2664453C1 |
| DERIVATIVES OF 4-PHENYLPYRROLIDONE WITH ANTICONVULSANT AND NOOTROPIC ACTIVITY AS MEANS OF TREATING EPILEPSY AND PAROXYSMAL CONDITIONS | 2017 |
|
RU2748419C2 |
| N-(4-ACETOXYBENZOYL)GLYCINE LITHIUM SALT POSSESSING TRANQUILISING AND NOOTROPIC ACTION | 2012 |
|
RU2505294C1 |
| REMEDY POSSESSING NOOTROPIC AND ADAPTATION PROPERTIES AND METHOD FOR PRODUCING THE REMEDY | 1996 |
|
RU2130314C1 |
| NEUROTROPIC DRUG AND METHOD FOR ITS PRODUCTION | 2007 |
|
RU2359962C1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
